Filed Under:Health Insurance, Individual Health

Type 1 diabetes 'reverse vaccine' promises to let patients forget about insulin needles

from the Verge

Those who are suffering with Type 1 diabetes may be able to ditch the needles in the future, thanks to a new treatment that enables patients to produce their own insulin instead of having to inject it. Dr. Lawrence Steinman of Stanford University recently announced that the new treatment has passed its first human test, paving the way for wider use in the future.

The so-called "reverse vaccine" works by suppressing the immune system at the DNA level, which in turn stimulates insulin production. It could stand to be the first DNA-based vaccine approved for human use. ... 

To read the full article, click here.

Top Sales and Marketing Ideas - 2014

Special Feature

2014 100 Best Sales & Marketing Ideas

There are a million ways to sell an insurance product, and any one of them may work depending on your target market, your product lineup and your own unique skill set.

Explore Now
More Resources

Comments

   

Advertisement. Closing in 15 seconds.